ARTICLE | Distillery Therapeutics
CX3CL1 gene therapy for retinitis pigmentosa
May 6, 2019 7:20 PM UTC
INDICATION: Retinitis...
BCIQ Company Profiles
BCIQ Target Profiles
INDICATION: Retinitis...
BCIQ Company Profiles
BCIQ Target Profiles
BCIQ Company Profiles
BCIQ Target Profiles